This interactive webinar considers the filing and post-filing data requirements for biotechnology and pharmaceutical-related inventions in China and
The 2019 Status Report on IPR Infringement from the European Union Intellectual Property Office (EUIPO) reveals that the annual sales lost
Earlier this year the first compulsory license, regarding the anti-cancer drug Sorafenib, was granted in India. (See previous blog
On 8 December 2011, the Court of Justice of the European Union (CJEU) issued its judgment in case C-125/10
Counterfeit pharmaceuticals case settled without main hearing In April 2010 Eli Lilly and Company (“Lilly”), the manufacturer of the